Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. MedSci Healthcare Holdings's interest expense for the
six
months ended in Dec. 2025 was HK$ -0.1 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.2 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. MedSci Healthcare Holdings Ltd has enough cash to cover all of its debt. Its financial situation is stable.
MedSci Healthcare Holdings Interest Expense Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedSci Healthcare Holdings (HKSE:02415) has a Interest Expense of HK$-0.2 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on MedSci Healthcare Holdings and its competitors.
Is MedSci Healthcare Holdings' Interest Expense too high?
MedSci Healthcare Holdings' current Interest Expense is HK$-0.2 Mil. Overall, MedSci Healthcare Holdings has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedSci Healthcare Holdings' Interest Expense compare to VEEV and BTSG?
MedSci Healthcare Holdings' Interest Expense of HK$-0.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on MedSci Healthcare Holdings and its competitors. MedSci Healthcare Holdings's current Interest Expense is HK$-0.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedSci Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, MedSci Healthcare Holdings (HKSE:02415) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.43, compared to a current price of HK$0.76 — trading 46.9% below its estimated fair value. The current Interest Expense is HK$-0.2 Mil. MedSci Healthcare Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For MedSci Healthcare Holdings (HKSE:02415), the current Interest Expense is HK$-0.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedSci Healthcare Holdings (HKSE:02415) Overvalued in 2026?
Based on GuruFocus' analysis, MedSci Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.76 is trading 46.9% below its estimated GF Value™ of HK$1.43.
GuruFocus considers MedSci Healthcare Holdings to be Possible Value Trap.
Key valuation signals for HKSE:02415:
Interest Expense: HK$-0.2 Mil
GF Value™: HK$1.43 vs. price of HK$0.76 (46.9% below fair value)
No single metric tells the full story. See the HKSE:02415 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
75GF Score
Get the complete analysis for HKSE:02415
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02415 has been successfully added to your 
